Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy (NCT07624903) | Clinical Trial Compass
Not Yet RecruitingPhase 2
Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
Egypt70 participantsStarted 2026-06
Plain-language summary
The aim of work is to study the effectiveness of letrozole in treatment of early undisturbed ectopic pregnancy in comparison with Methotrexate.
Who can participate
Age range
20 Years – 35 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Confirmed ectopic pregnancy on trans vaginal ultrasound
* Age between 20 and 35 years
* A β-hCG levels \< 3000 Iu/ L
* The average diameter of the adnexal mass ≤3.5 cm
* Stable hemodynamic condition
Exclusion Criteria:
* Presence of fetal heart pulsation
* Heterotopic pregnancy
* Presence of significant abdominal pain
* history of allergic reactions to MTX or letrozole
* Any known liver disorder or abnormal liver enzyme levels (AST or ALT )
* Any known renal disorder or impaired renal function tests (abnormal creatinine)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Resolution of complain
Timeframe: β-hCG will be repeated weekly till negative or until the maximum dose of medication is reached (four doses of Methotrexate , whichever comes first).
Trial details
NCT IDNCT07624903
SponsorKafrelsheikh University
Sponsor typeOTHER
Study typeINTERVENTIONAL
Primary completion2027-06
Contact for this trial
Aya Fekry Saad Bahnasy, Obstetrics&Gynecology resident